Supply of polyvalent immunoglobulins for subcutaneous administration

Summary

The tender is for polyvalent normal human immunoglobulins for subcutaneous administration in strengths of 1 g, 2 g and 4 g. It is a framework agreement with one supplier and a maximum order value of EUR 1,085,000 excluding VAT. The supply period runs from 4 January 2027 to 3 January 2031, and price is the only award criterion. Tenders must be submitted electronically by 09:00 on 12 October 2026. The tenderer must provide evidence that the product is reimbursable, the scientific package leaflet in PDF format, and proof of Belgian marketing registration for each offered medicinal form.